Mark L. Kahn

14.6k total citations · 4 hit papers
132 papers, 10.3k citations indexed

About

Mark L. Kahn is a scholar working on Hematology, Surgery and Oncology. According to data from OpenAlex, Mark L. Kahn has authored 132 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hematology, 33 papers in Surgery and 30 papers in Oncology. Recurrent topics in Mark L. Kahn's work include Platelet Disorders and Treatments (42 papers), Lymphatic System and Diseases (28 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). Mark L. Kahn is often cited by papers focused on Platelet Disorders and Treatments (42 papers), Lymphatic System and Diseases (28 papers) and Blood Coagulation and Thrombosis Mechanisms (20 papers). Mark L. Kahn collaborates with scholars based in United States, Australia and China. Mark L. Kahn's co-authors include Shaun R. Coughlin, Hiroaki Ishihara, Andrew J. Connolly, Dewan Zeng, Robert V. Farese, Mayumi Nakanishi‐Matsui, Michael J. Shapiro, Paul R. Hess, Hong Chen and Zhiying Zou and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark L. Kahn

128 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A dual thrombin receptor system for platelet activation

1998 788 citations Mark L. Kahn, Robert V. Farese et al. Nature profile →
Protease-activated receptor 3 is a second thrombin receptor in humans

1997 756 citations Hiroaki Ishihara, Andrew J. Connolly et al. Nature profile →
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin

1999 661 citations Mark L. Kahn, Hiroaki Ishihara et al. Journal of Clinical Investigation profile →
Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation

2018 197 citations Lauren M. Goddard, Mark L. Kahn et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Mark L. Kahn

Since Specialization

Citations

This map shows the geographic impact of Mark L. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Kahn more than expected).

Fields of papers citing papers by Mark L. Kahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Kahn. The network helps show where Mark L. Kahn may publish in the future.

Co-authorship network of co-authors of Mark L. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Kahn. A scholar is included among the top collaborators of Mark L. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Kahn. Mark L. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lineage tracing studies suggest that the placenta is not a de novo source of hematopoietic stem cells 2025 ·PLoS Biology ·Xiaowen Chen, Joanna Tober, Martin H. Dominguez, Alan T. Tang, (unknown), Jisheng Yang, Sneha Mani, (unknown), Mei Chen, (unknown), (unknown), Monica Mainigi, Nancy A. Speck, Mark L. Kahn	1
2	GPR124 regulates murine brain embryonic angiogenesis and BBB formation by an intracellular domain-independent mechanism 2024 ·Development ·(unknown), Mario Vallon, Jie Ding, (unknown), Alan T. Tang, José G. Vilches-Moure, (unknown), (unknown), (unknown), Barbara M. Braunger, Süleyman Ergün, Mark L. Kahn, Calvin J. Kuo	5
3	Endothelial SARS-CoV-2 infection is not the underlying cause of COVID-19-associated vascular pathology in mice 2023 ·Frontiers in Cardiovascular Medicine ·Siqi Gao, Alan T. Tang, (unknown), David W. Buchholz, (unknown), Jisheng Yang, Xiaowen Chen, Peter Hewins, (unknown), N. Adrian Leu, Stephanie Sterling, Avery August, Kellie A. Jurado, Edward E. Morrisey, (unknown), Mark L. Kahn	4
4	No crops without seeds: the risks in declining support for fundamental research 2023 ·Nature Cardiovascular Research ·Benjamin M. Hogan, Mark L. Kahn, Natasha L. Harvey	2
5	mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice 2023 ·Stroke ·Lun Li, Aileen A. Ren, Siqi Gao, YouRong Sophie Su, Jisheng Yang, (unknown), (unknown), (unknown), Robert Shenkar, (unknown), Thomas Moore, Rhonda Lightle, (unknown), Issam A. Awad, Douglas A. Marchuk, Mark L. Kahn, Jan‐Karl Burkhardt	7
6	Endothelial MEKK3-KLF2/4 signaling integrates inflammatory and hemodynamic signals during definitive hematopoiesis 2022 ·Blood ·Yi‐Qing Yang, Melanie Mumau, Joanna Tober, Qin Zhu, Laura Bennett, Courtney C. Hong, Derek C. Sung, T.C. Stevenson Keller, Yasin Uzun, Peng Gao, Swapnil V. Shewale, Mei Chen, Jisheng Yang, Xiaowen Chen, Steven Thomas, Kai Tan, Nancy A. Speck, Mark L. Kahn	11
7	Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C–CDH5 inhibition 2022 ·Nature Cardiovascular Research ·Derek C. Sung, Mei Chen, Martin H. Dominguez, (unknown), Xiaowen Chen, Jisheng Yang, Siqi Gao, Aileen A. Ren, Alan T. Tang, Patricia Mericko, (unknown), Michelle Lee, Melanie Jannaway, Astrid F. Nottebaum, Dietmar Vestweber, Joshua P. Scallan, Mark L. Kahn	7
8	Developmental venous anomalies are a genetic primer for cerebral cavernous malformations 2022 ·Nature Cardiovascular Research ·Daniel Snellings, Romuald Girard, Rhonda Lightle, Abhinav Srinath, Sharbel Romanos, (unknown), Chang Chen, Aileen A. Ren, Mark L. Kahn, Issam A. Awad, Douglas A. Marchuk	27
9	Cerebral Cavernous Malformation: From Mechanism to Therapy 2021 ·Circulation Research ·Daniel Snellings, Courtney C. Hong, Aileen A. Ren, Miguel Alejandro Lopez‐Ramirez, Romuald Girard, Abhinav Srinath, Douglas A. Marchuk, Mark H. Ginsberg, Issam A. Awad, Mark L. Kahn	79
10	Chemokine mediated signalling within arteries promotes vascular smooth muscle cell recruitment 2020 ·Communications Biology ·Amber N. Stratman, Margaret C. Burns, Olivia Farrelly, (unknown), Wenling Li, Van N. Pham, Daniel Castranova, (unknown), Lauren M. Goddard, (unknown), Marina Venero Galanternik, (unknown), Mark L. Kahn, Yoh‐suke Mukouyama, Brant M. Weinstein	28
11	Hemodynamic regulation of perivalvular endothelial gene expression prevents deep venous thrombosis 2019 ·Journal of Clinical Investigation ·John D. Welsh, Mark H. Hoofnagle, Sharika Bamezai, (unknown), Lillian Yuxian Lim, Joshua D. Hall, Jisheng Yang, Susan K. Schultz, James Douglas Engel, Tsutomu Kume, Guillermo Oliver, Juan M. Jiménez, Mark L. Kahn	40
12	Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD 2016 ·Journal of Clinical Investigation ·Hung Bui, David R. Enis, Marius R. Robciuc, Harri Nurmi, Jennifer D. Cohen, Mei Chen, Yi‐Qing Yang, (unknown), Kathy Johnson, Hong Zhang, Robert B. Kirkpatrick, Elizabeth A. Traxler, Andrey Anisimov, Kari Alitalo, Mark L. Kahn	108
13	Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease 2016 ·Journal of Neuroscience Methods ·Romuald Girard, Hussein A. Zeineddine, Courtney P. Orsbon, Huan Tan, Thomas Moore, (unknown), Robert Shenkar, Rhonda Lightle, Changbin Shi, Maged D Fam, Ying Cao, Le Shen, April I. Neander, (unknown), Carol J. Gallione, Alan T. Tang, Mark L. Kahn, Douglas A. Marchuk, Zhe‐Xi Luo, Issam A. Awad	16
14	Lymphatic function is required prenatally for lung inflation at birth 2014 ·The Journal of Experimental Medicine ·Zoltán Jakus, Jason P. Gleghorn, David R. Enis, (unknown), (unknown), Xi Liu, David R. Rawnsley, Yi‐Qing Yang, Paul R. Hess, Zhiying Zou, Jisheng Yang, Susan H. Guttentag, Celeste M. Nelson, Mark L. Kahn	61
15	Small-molecule inhibitors of integrin α ₂ β ₁ that prevent pathological thrombus formation via an allosteric mechanism 2009 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Daniel W. Kulp, Paul C. Billings, Sungwook Choi, Mary Pat Beavers, Owen J. T. McCarty, Zhiying Zou, Mark L. Kahn, Joel Bennett, William F. DeGrado	65
16	Regulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk 2003 ·Science ·Farhad Abtahian, Anastasia Guerriero, Eric Sebzda, Minmin Lu, Rong Zhou, Attila Mócsai, (unknown), Bin Huang, David G. Jackson, Victor A. Ferrari, Victor L. J. Tybulewicz, Clifford A. Lowell, John J. Lepore, Gary A. Koretzky, Mark L. Kahn	330
17	Platelet collagen receptor glycoprotein VI as a novel risk factor for myocardial infarction 2003 ·Journal of the American College of Cardiology ·Frederick F. Samaha, Michael Varello, Mark L. Kahn	1
18	Separation of blood and lymphatic vascular networks is regulated by the hematopoietic signaling proteins SLP-76 and Syk. 2002 ·Blood ·Farhad Abtahian, Anastasia Guerriero, (unknown), (unknown), Attila Mócsai, (unknown), Bin Huang, Darryl Jackson, Victor A. Ferrari, Victor L. J. Tybulewicz, Clifford A. Lowell, John J. Lepore, Gary A. Koretzky, Mark L. Kahn	1
19	Delayed Onset of Inflammation in Protease-Activated Receptor-2-Deficient Mice 2000 ·The Journal of Immunology ·Jonathan R. Lindner, Mark L. Kahn, Shaun R. Coughlin, Gilberto R. Sambrano, Eric Schauble, Daniel Bernstein, Dan Foy, Ali Hafezi‐Moghadam, Klaus Ley	234
20	Role of the thrombin receptor in development and evidence for a second receptor 1996 ·Nature ·Andrew J. Connolly, Hiroaki Ishihara, Mark L. Kahn, Robert V. Farese, Shaun R. Coughlin	411

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact